Deep Dive
来自我们记者的行业洞察
FDA's Laboratory-Developed Test (LDT) Program Halted by Court: Industry Impact and Future Directions
On March 31, a U.S. federal court ruled that the FDA's final rule treating laboratory-developed tests (LDTs) as medical devices is invalid. Multiple regulatory affairs lawyers stated that the FDA may not appeal, but the possibility remains for Congress to legislate reform of the LDT regulatory framework, though it is unlikely to be achieved in the near term.
Legal Experts Question: HHS Mass Layoffs May Violate the Law
The mass layoffs at the U.S. Department of Health and Human Services (HHS) may violate federal law. Legal experts point out issues such as the closure of statutory offices, improper definition of competitive areas, and erroneous notification information during the layoff process. Unions and law firms have begun preparing legal challenges.
Healthcare industry navigates AI regulatory challenges on its own in absence of federal guidance
In the absence of federal AI standards, the healthcare industry is striving to establish its own regulatory frameworks. The Trump administration's laissez-faire approach leaves hospitals and developers in a regulatory gray area, while states and industry organizations begin to fill the void. Experts warn that rapid technological advancement coupled with lagging governance may pose risks.
Electronic medical record vendors race to introduce AI, driving modernization of medical record systems
Medical record companies are racing to integrate artificial intelligence into multiple parts of their software to streamline cumbersome operations and attract customers. Major suppliers such as Epic and Oracle have recently announced or accelerated modernization plans aimed at boosting productivity and improving the doctor-patient experience. Despite quality, privacy, and regulatory concerns, hospital customers are adopting with great enthusiasm.
Will artificial intelligence increase the burden on clinicians?
The promotion of medical AI promises time savings, but experts warn that physicians' verification of AI outputs may offset time gains, while fee-for-service incentives may fill saved time with more patient visits.
U.S. health insurers face pressure at the end of 2024: rising medical loss ratios cast a shadow over profit prospects
In the fourth quarter of 2024, the average medical loss ratio of major U.S. publicly listed health insurers rose by 2.8 percentage points, with most companies seeing declines in insurance business profits. Although some insurers are improving 2025 profitability by cutting unprofitable Medicare Advantage members, persistently high medical costs, inadequate Medicaid rates, and policy uncertainty remain significant challenges.
2025 Healthcare Providers Focus on Efficiency Gains and Supply Chain Resilience
Healthcare providers are expected to continue prioritizing efficiency maximization in 2025, while navigating cost pressures, supply chain challenges, and uncertainties arising from new government policies. Experts note that despite improved operating margins in 2024, systems still need to carefully control costs and explore strategic growth opportunities.
2025 Medical Technology Trends Outlook: AI Regulation, Cybersecurity, and Telemedicine Take Center Stage
In 2025, the medical technology sector will face multiple challenges and opportunities: AI regulation enters a new government term, the temporary telemedicine exemption is extended only until March, cyber attack threats persist, and digital health investment and financing may see a rebound. This article outlines four key trends.
